Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secondary Prophylaxis After Variceal Bleeding: EVL + Nadolol vs Hemodynamic-Guided Pharmacotherapy
NCT00450164Phase 4Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Nov 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of isosorbide mononitrate and prazosin in Esophageal variceal hemorrhage (EVH) and gastric varices (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Compared efficacy at 6 months. Started Nov 2000; status: completed.
02
Drugs
isosorbide mononitrateprazosin
03
Conditions
Esophageal variceal hemorrhage (EVH)gastric varices
Beyond the preview
Go deeper on NCT00450164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00450164.